The Global Artificial Insemination Market was valued at USD 2.1 billion in 2023 and is projected to reach USD 4.3 billion by 2031, growing at a CAGR of 9.2%. The market is expanding due to rising infertility rates, advancements in assisted reproductive technology (ART), and an increasing acceptance of AI procedures in both humans and livestock.
2024 Market Breakthroughs
- Human AI Innovations:
- Vitrolife’s AI Sperm Selection System improves pregnancy rates by 22% through AI-based morphology analysis.
- CooperSurgical’s Gavi® Sperm Prep reduces DNA fragmentation by 30%, which enhances fertilization success.
- Livestock AI Advancements:
- STgenetics’ SexedULTRA™ achieves 95% accuracy in gender selection for cattle breeding.
- ABS Global’s InForce™ extends sperm viability to 72 hours post-thawing.
- Regulatory & Tech Shifts:
- FDA approves AI-powered semen analyzers for at-home fertility testing (2024).
- EU’s Animal Breeding Regulation mandates genomic screening for all AI livestock semen.
Market Drivers
- Rising Infertility Rates
- 1 in 6 couples globally face infertility (WHO, 2024).
- Delayed parenthood trends (avg. first-time mothers now 31.5 years in developed nations).
- Livestock Industry Demand
- Dairy sector drives 60% of livestock AI market (high-yield breeding).
- Pork & poultry industries adopt AI to improve genetic traits.
- Technological Advancements
- AI-based sperm selection increases IVF success rates.
- Cryopreservation tech improves post-thaw sperm survival.
Competitive Landscape
|
Company
|
Market Share
|
Flagship Innovation
|
Strategic Edge
|
|
CooperSurgical
|
28%
|
Gavi® Sperm Prep
|
Leading human fertility segment
|
|
STgenetics
|
22%
|
SexedULTRA™ gender-sorted semen
|
Livestock AI dominance
|
|
Vitrolife
|
XX%
|
AI Sperm Selection System
|
High IVF clinic adoption
|
Emerging Disruptors:
- TMRW Life Sciences: Automated cryo-storage for AI samples (Series C: USD 75M).
- Mojo Fertility: At-home AI sperm testing kit (FDA-cleared, 2024).
Market Segmentation
- By Type:
- Intrauterine Insemination (IUI) (55%) – Most common human AI procedure.
- Intracervical Insemination (ICI) (XX%) – Lower-cost alternative.
- Livestock AI (XX%) – Fastest-growing (12% CAGR).
- By End-User:
- Fertility Clinics (XX%) – High adoption of advanced AI tech.
- Home Insemination (XX%) – Rising due to telehealth & at-home kits.
- Animal Breeding (XX%) – Dairy & poultry industries dominate.
- By Region:
- North America (35%) – High IVF adoption & advanced livestock AI.
- Europe (XX%) – Strict regulations drive premium AI solutions.
- Asia-Pacific (XX%) – Rapidly growing due to rising infertility rates.
Recent Developments (2024)
- May 2024: FDA approves first AI-powered at-home semen analyzer (Mojo Fertility).
- July 2024: ABS Global partners with CRISPR firms for gene-edited livestock semen.
